NEWARK, NJ, October 8, 2019 – Donald H. Sebastian, NJII CEO and president, Tomas Gregorio, senior vice president NJII healthcare division and Haro Hartouinian, senior executive director NJII biotechnology and pharmaceutical innovation have been named to ROI-NJ Influencers: Health Care 2019. New Jersey Innovation Institute is an NJIT Corporation.
In making the announcement ROI-NJ stated, “Sprouting up from its Newark roots, New Jersey Institute of Technology has seen significant growth onto a broader statewide landscape in recent years. Thanks, in part, to the advocacy of Sebastian, and his stellar team in Tom Gregorio and Haro Hartounian. The three make up the key force behind NJII’s health care leadership in the innovation space, and their strategic partnerships with Rutgers and HMH, as well as the state, have played out well. The institute is especially growing in the gene therapy space, which is a trending area in the life sciences. Sebastian is well-connected at the highest levels of state government, and works comfortably alongside some of the most influential business leaders in the state and country.”
The New Jersey Innovation Institute (NJII) is an NJITcorporation that applies the intellectual and technological resources of New Jersey’s public polytechnic university to challenges identified by industry partners. Through its Innovation Labs (iLabs), NJII brings NJIT expertise to key economic sectors, including healthcare delivery systems, bio-pharmaceutical production, civil infrastructure, defense and homeland security, and financial services.
As a top PPP lender, Cross River provided more than $6.5 billion in relief to nearly 200,000 small businesses, saving nearly one million jobs to